Showing results (81-90 of 144) with videos related to
Sort By:
Pageof 15
Psycho-Oncology|August 26, 2021
Psychological distress in primary caregivers of children with cancer during COVID-19 pandemic-A single tertiary care center experienceBadira Cheriyalinkal Parambil, Savita Goswami, Nirmalya Roy Moulik, et al.Cytometry. Part B, Clinical Cytometry|January 17, 2020
CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemiaPratyusha Gudapati, Twinkle Khanka, Gaurav Chatterjee, et al.Journal De Mycologie Medicale|November 7, 2024
Prevalence and outcome of candidemia among paediatric cancer patients: A single centre experience from IndiaPoonam Khemani, Shyam Srinivasan, Gaurav Salunke, et al.Cancer Medicine|January 6, 2024
Performance of potentially inappropriate medications assessment tools in older Indian patients with cancerSharath Kumar, Renita Castelino, Abhijith Rao, et al.Trials|February 1, 2022
Protocol for ICiCLe-ALL-14 (InPOG-ALL-15-01): a prospective, risk stratified, randomised, multicentre, open label, controlled therapeutic trial for newly diagnosed childhood acute lymphoblastic leukaemia in IndiaNandana Das, Shripad Banavali, Sameer Bakhshi, et al.Journal of Gastrointestinal Cancer|November 23, 2022
Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, Over the Past 15 YearsVanita Noronha, Anbarasan Sekar, Akhil Rajendra, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global ChallengeCarlos Rodriguez-Galindo, Paola Friedrich, Patricia Alcasabas, et al.Mediterranean Journal of Hematology and Infectious Diseases|January 13, 2018
Molecular Heterogeneity in Acute Promyelocytic Leukemia - a Single Center Experience from IndiaNikhil Rabade, Goutham Raval, Shruti Chaudhary, et al.Cytometry. Part B, Clinical Cytometry|August 20, 2020
Eleven-marker 10-color flow cytometric assessment of measurable residual disease for T-cell acute lymphoblastic leukemia using an approach of exclusionPrashant R Tembhare, Gaurav Chatterjee, Twinkle Khanka, et al.Indian Journal of Pathology & Microbiology|June 21, 2017
An integrated genomic profile that includes copy number alterations is highly predictive of minimal residual disease status in childhood precursor B-lineage acute lymphoblastic leukemiaNikhil Patkar, P G Subramanian, Prashant Tembhare, et al.Pageof 15